{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T06:37:49Z","timestamp":1790318269300,"version":"4.1.0"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2191,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1111\/j.1365-2133.2009.09230.x","type":"journal-article","created":{"date-parts":[[2009,5,12]],"date-time":"2009-05-12T18:10:50Z","timestamp":1242151850000},"page":"660-663","source":"Crossref","is-referenced-by-count":59,"title":["Gemcitabine treatment in cutaneous T-cell lymphoma: a multicentre study of 23 cases"],"prefix":"10.1093","volume":"161","author":[{"given":"K.","family":"Jidar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Ingen-Housz-Oro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Beylot-Barry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Chaoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Sigal-Grinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Morel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Dubertret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Bachelez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"10.1111\/j.1365-2133.2009.09230.x-BIB1","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"key":"10.1111\/j.1365-2133.2009.09230.x-BIB2","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1093\/ajhp\/54.2.162","article-title":"Gemcitabine: a cytidine analogue active against solid tumors","volume":"54","author":"Hui","year":"1997","journal-title":"Am J Health Syst Pharm"},{"key":"10.1111\/j.1365-2133.2009.09230.x-BIB3","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1002\/1097-0142(20000601)88:11<2505::AID-CNCR11>3.0.CO;2-E","article-title":"A phase II trial of biweekly high dose gemcitabine for patients with metastatic pancreatic adenocarcinoma","volume":"88","author":"Ulrich-Pur","year":"2000","journal-title":"Cancer"},{"key":"10.1111\/j.1365-2133.2009.09230.x-BIB4","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/1097-0142(20000801)89:3<516::AID-CNCR6>3.0.CO;2-9","article-title":"Treatment of patients with advanced non-small-cell lung carcinoma using docetaxel and gemcitabine plus granulocyte-colony stimulating factor","volume":"89","author":"Hejna","year":"2000","journal-title":"Cancer"},{"key":"10.1111\/j.1365-2133.2009.09230.x-BIB5","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1200\/JCO.2000.18.13.2529","article-title":"Gemcitabine plus vinorelbine versus vinorelbine alone in elderly patients with advanced non-small-cell lung cancer","volume":"18","author":"Frasci","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1111\/j.1365-2133.2009.09230.x-BIB6","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1097\/00001622-200111000-00015","article-title":"Gemcitabine in hematologic malignancies","volume":"13","author":"Nabhan","year":"2001","journal-title":"Curr Opin Oncol"},{"key":"10.1111\/j.1365-2133.2009.09230.x-BIB7","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1023\/A:1008498219576","article-title":"Gemcitabine: a major advance?","volume":"9","author":"Thomas","year":"1998","journal-title":"Ann Oncol"},{"key":"10.1111\/j.1365-2133.2009.09230.x-BIB8","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1023\/A:1008409601731","article-title":"Therapy with gemcitabine in pretreated peripheral T-cell lymphoma patients","volume":"9","author":"Zinzani","year":"1998","journal-title":"Ann Oncol"},{"key":"10.1111\/j.1365-2133.2009.09230.x-BIB9","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1002\/cncr.21449","article-title":"Gemcitabine as frontline treatment for cutaneous T-cell lymphoma: phase II study of 32 patients","volume":"104","author":"Marchi","year":"2005","journal-title":"Cancer"},{"key":"10.1111\/j.1365-2133.2009.09230.x-BIB10","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1200\/JCO.2000.18.13.2603","article-title":"Gemcitabine treatment in pretreated cutaneous T-cell lymphoma: experience in 44 patients","volume":"13","author":"Zinzani","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1111\/j.1365-2133.2009.09230.x-BIB11","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/00001813-199803000-00001","article-title":"Gemcitabine - a safety review","volume":"9","author":"Aapro","year":"1998","journal-title":"Anticancer Drugs"},{"key":"10.1111\/j.1365-2133.2009.09230.x-BIB12","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3816\/CLM.2006.n.039","article-title":"Phase II evaluation of gemcitabine monotherapy for cutaneous T-cell lymphoma","volume":"7","author":"Duvic","year":"2006","journal-title":"Clin Lymphoma Myeloma"},{"key":"10.1111\/j.1365-2133.2009.09230.x-BIB13","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1046\/j.1365-2141.2001.02743.x","article-title":"Treatment of refractory T-cell malignancies using gemcitabine","volume":"113","author":"Sallah","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1365-2133.2009.09230.x-BIB14","first-page":"369","article-title":"Hemolytic-uremic syndrome associated with gemcitabine. A case report and review of literature","volume":"6","author":"Saif","year":"2005","journal-title":"JOP"},{"key":"10.1111\/j.1365-2133.2009.09230.x-BIB15","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1002\/cncr.20290","article-title":"Gemcitabine-associated thrombotic microangiopathy","volume":"100","author":"Humphreys","year":"2004","journal-title":"Cancer"},{"key":"10.1111\/j.1365-2133.2009.09230.x-BIB16","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1093\/ndt\/gfl507","article-title":"Gemcitabine-induced thrombotic microangiopathy: a systematic review","volume":"21","author":"Izzedine","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1365-2133.2009.09230.x-BIB17","first-page":"179","article-title":"Hemolytic uremic syndrome as a complication of gemcitabine treatment: report of six cases and review of the literature","volume":"26","author":"Desrame","year":"2005","journal-title":"Rev Med Interne"},{"key":"10.1111\/j.1365-2133.2009.09230.x-BIB18","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.clon.2005.09.003","article-title":"Gemcitabine induced chronic systemic capillary leak syndrome: a life-threatening disease","volume":"18","author":"Baron","year":"2006","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1111\/j.1365-2133.2009.09230.x-BIB19","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.clon.2004.06.019","article-title":"Severe gemcitabine-induced capillary-leak syndrome mimicking cardiac failure in a patient with advanced pancreatic cancer and high-risk cardiovascular disease","volume":"16","author":"Biswas","year":"2004","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1111\/j.1365-2133.2009.09230.x-BIB20","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/01.COC.0000017782.24458.DD","article-title":"Gemcitabine induced peripheral edema","volume":"26","author":"Azzoli","year":"2003","journal-title":"Am J Clin Oncol"},{"key":"10.1111\/j.1365-2133.2009.09230.x-BIB21","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1023\/A:1013163831194","article-title":"Gemcitabine-induced systemic capillary leak syndrome","volume":"12","author":"De Pas","year":"2001","journal-title":"Ann Oncol"},{"key":"10.1111\/j.1365-2133.2009.09230.x-BIB22","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1179\/joc.2003.15.3.287","article-title":"Systemic capillary leak syndrome resulting from gemcitabine treatment in renal cell carcinoma: a case report","volume":"15","author":"Pulkkanen","year":"2003","journal-title":"J Chemother"},{"key":"10.1111\/j.1365-2133.2009.09230.x-BIB23","first-page":"552","article-title":"Gemcitabine-induced severe extremity edema with muscle contractures and subsequent prevention with prednisone","volume":"2","author":"Geffen","year":"2000","journal-title":"Isr Med Assoc J"},{"key":"10.1111\/j.1365-2133.2009.09230.x-BIB24","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1097\/00001813-200309000-00012","article-title":"Stevens-Johnson syndrome\/toxic epidermal necrolysis in a patient receiving concurrent radiation and gemcitabine","volume":"14","author":"Sommers","year":"2003","journal-title":"Anticancer Drugs"},{"key":"10.1111\/j.1365-2133.2009.09230.x-BIB25","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.rmed.2005.11.027","article-title":"Bullous dermatosis associated with gemcitabine therapy for non-small-cell lung carcinoma","volume":"100","author":"Imen","year":"2006","journal-title":"Respir Med"},{"key":"10.1111\/j.1365-2133.2009.09230.x-BIB26","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1023\/A:1008305716918","article-title":"Sudden cardio-pulmonary toxicity following a single infusion of gemcitabine","volume":"10","author":"Ciotti","year":"1999","journal-title":"Ann Oncol"},{"key":"10.1111\/j.1365-2133.2009.09230.x-BIB27","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1023\/A:1008380208045","article-title":"Gemcitabine-induced atrial fibrillation: a hitherto unreported manifestation of drug toxicity","volume":"11","author":"Santini","year":"2000","journal-title":"Ann Oncol"},{"key":"10.1111\/j.1365-2133.2009.09230.x-BIB28","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0169-5002(00)00194-X","article-title":"Activity and toxicity of gemcitabine and gemcitabine\u2003+\u2003vinorelbine in advanced non-small-cell lung cancer elderly patients: phase II data from the Multicenter Italian Lung Cancer in the Elderly Study (MILES) randomized trial","volume":"31","author":"Gridelli","year":"2001","journal-title":"Lung Cancer"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2009.09230.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2133.2009.09230.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T13:45:29Z","timestamp":1676382329000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/161\/3\/660\/6642029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,9]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2133.2009.09230.x","relation":{},"ISSN":["0007-0963","1365-2133"],"issn-type":[{"value":"0007-0963","type":"print"},{"value":"1365-2133","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}